Evidence map›Paper›PMID 32292165›Full record

ArticleeLife2020

STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism.

Sung Jun Bae, Lisheng Ni, Xuelian Luo

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. STRIPAK, a fundamental signaling hub of eukaryotic development.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sung Jun BaeDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, United States.
Lisheng NiDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, United States.
Xuelian LuoDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, United States.ORCID 0000-0002-5058-4695
The University of Texas Southwestern Medical Center · US

Funding

Mechanism and Regulation of STRIPAK–SLMAP in Hippo SignalingR01GM132275 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI LUO, XUELIAN · 2019 to 2022
$1.6M
Activation mechanism of the tumor-suppressing MST-LATS kinase cascadeR01GM107415 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI LUO, XUELIAN · 2013 to 2016
$1.2M
NIGMS NIH HHS GM107415NIGMS NIH HHS R01 GM107415NIGMS NIH HHS R01 GM132275
6 · The paper itself

Abstract

The MST-LATS kinase cascade is central to the Hippo pathway that controls tissue homeostasis, development, and organ size. The PP2A complex STRIPAK

Indexed as

Cell Cycle ProteinsCells, CulturedHippo KinasesHippo Signaling PathwayHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsPhosphorylationProtein Phosphatase 2Protein Serine-Threonine KinasesSerine-Threonine Kinase 3Signal TransductionCell Cycle ProteinsHippo KinasesIntracellular Signaling Peptides and ProteinsMembrane ProteinsProtein Phosphatase 2Protein Serine-Threonine KinasesSAV1 protein, humanSerine-Threonine Kinase 3SLMAP protein, humanSTK25 protein, humanSTK3 protein, humanSTK4 protein, humancell biologyEscherichia colihumanhuman 293A cellhuman 293FT cell

Identifiers

PMID32292165
PMCPMC7182433
OpenAlexW3015209620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.